心脏手术后初始液体耐受且前负荷反应患者液体负荷后全身静脉淤血的发生率、可预测性及结局:一项先导试验
该单中心前瞻性观察性先导试验纳入40例择期开胸心脏手术后6小时内机械通气且存在急性循环衰竭、同时液体耐受且前负荷反应的患者,给予7 ml/kg乳酸林格液10分钟输注。45%患者出现早期静脉淤血(输注后2分钟),20分钟时仅5%持续存在;三分之一发生急性肾损伤,17.5%进展为严重急性肾损伤,中位ICU住院时间4天。早期静脉淤血患者中心静脉压更高、平均灌注压更低、基线右心室功能更差且严重急性肾损伤发生率更高;被动抬腿试验后门静脉搏动指数以44.3%为阈值预测早期静脉淤血的曲线下面积为0.998(p < 0.001)。作者认为该指标可指导心脏手术患者的液体管理,帮助避免不必要的液体输注及相关并发症。
要点
- 液体耐受且前负荷反应的心脏手术后患者中,7 ml/kg乳酸林格液10分钟输注后2分钟45%出现早期静脉淤血,20分钟时仅5%持续存在。
- 早期静脉淤血患者严重急性肾损伤发生率更高,且中心静脉压更高、平均灌注压更低、基线右心室功能更差。
- 被动抬腿试验后门静脉搏动指数预测早期静脉淤血曲线下面积0.998,阈值44.3%(p < 0.001)。
- 尽管两组左心室流出道速度时间积分20分钟均回到基线,早期静脉淤血组门静脉搏动指数仍升高(p < 0.001),提示右心室舒张储备降低。
- 作者认为被动抬腿试验后门静脉搏动指数可指导心脏手术患者液体管理,帮助避免不必要的液体输注及相关并发症。
适用人群与场景
- 择期开胸心脏手术后6小时内入住ICU、机械通气且存在急性循环衰竭的患者。
- 纳入标准:同时满足液体耐受和前负荷反应;前负荷反应定义为被动抬腿试验后1分钟左心室流出道速度时间积分增加≥12%。
- 单中心连续纳入40例患者,研究期间为2023年5月至2024年7月。
诊断标准与关键阈值
- 前负荷反应:被动抬腿试验后1分钟左心室流出道速度时间积分增加≥12%。
- 静脉淤血:门静脉搏动指数≥50%。
- 早期静脉淤血:液体输注后2分钟门静脉搏动指数≥50%。
- 被动抬腿试验后门静脉搏动指数预测早期静脉淤血的阈值为44.3%,曲线下面积0.998(p < 0.001)。
处置流程与药物剂量
- 对液体耐受且前负荷反应的患者给予7 ml/kg乳酸林格液10分钟输注。
- 输注后2分钟和20分钟评估门静脉搏动指数以识别静脉淤血。
红旗征与不能漏的情况
- 早期静脉淤血患者中心静脉压更高、平均灌注压更低、基线右心室功能更差,且严重急性肾损伤发生率更高。
- 早期静脉淤血患者20分钟时门静脉搏动指数仍升高(p < 0.001),提示右心室舒张储备降低。
研究设计与关键结果
- 单中心前瞻性观察性先导试验,纳入40例择期开胸心脏手术后6小时内机械通气、急性循环衰竭、液体耐受且前负荷反应的患者。
- 主要终点:输注后2分钟早期静脉淤血发生率为45%;20分钟时静脉淤血持续存在者仅5%。
- 次要终点:三分之一患者发生急性肾损伤,17.5%进展为严重急性肾损伤;中位ICU住院时间4天。
- 早期静脉淤血组中心静脉压更高、平均灌注压更低、基线右心室功能更差、严重急性肾损伤发生率更高。
- 两组左心室流出道速度时间积分20分钟均回到基线,但早期静脉淤血组门静脉搏动指数仍升高(p < 0.001)。
- 左心室流出道速度时间积分与门静脉搏动指数回归线斜率相似(p = 0.755),截距不同(p < 0.001)。
- 被动抬腿试验后门静脉搏动指数预测早期静脉淤血曲线下面积0.998,阈值44.3%(p < 0.001)。
证据类型、等级与局限
- 证据类型:单中心前瞻性观察性先导试验。
- 试验注册号NCT06440772,回顾性注册。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,被动抬腿试验后门静脉搏动指数可有效预测液体耐受且前负荷反应的心脏手术后患者液体负荷后早期静脉淤血,识别右心室舒张储备差者。
- 作者认为,其使用可指导心脏手术患者的液体管理,帮助避免不必要的液体输注及相关并发症。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Fluid administration has traditionally focused on preload responsiveness (PR). However, preventing fluid intolerance, particularly due to systemic venous congestion (VC), is equally important. This study evaluated the incidence and predictability of VC following a 7 ml/kg crystalloid infusion in fluid-tolerant preload-responders and its association with adverse outcomes.
METHODS: This single-center, prospective, observational study (May 2023-July 2024) included 40 consecutive patients who were mechanically ventilated within 6 h of intensive care unit (ICU) admission after elective open-heart surgery and had acute circulatory failure. Patients were eligible if they were both fluid-tolerant and preload-responsive. PR was defined as a ≥ 12% increase in left-ventricular outflow tract velocity time integral (LVOT-VTI) 1 min after a passive leg raising (PLR) test. VC was defined by a portal vein pulsatility index (PVPI) ≥ 50%. Patients received a 7 ml/kg Ringer's Lactate infusion over 10 min. The primary outcome was the incidence of VC 2 min post-infusion (early-VC). Secondary outcomes included VC at 20 min, the incidence of acute kidney injury (AKI) and severe AKI at 7 days, and ICU length of stay (LOS).
RESULTS: 45% of patients developed early-VC, with VC persisting in only 5% at 20 min. One-third of patients developed AKI, with 17.5% progressing to severe AKI. The median ICU LOS was 4 days. Patients with early-VC had significantly higher central venous pressure, lower mean perfusion pressure, worse baseline right ventricular function, and a higher incidence of severe AKI. While LVOT-VTI returned to baseline by 20 min in both groups, PVPI remained elevated in early-VC patients (p < 0.001). The LVOT-VTI versus PVPI regression line showed similar slopes (p = 0.755) but different intercepts (p < 0.001), indicating that, despite fluid tolerance and PR at baseline, early-VC patients had reduced right ventricular diastolic reserve (RVDR). Post-PLR PVPI predicted early-VC with an area under the curve of 0.998, using a threshold of 44.3% (p < 0.001).
CONCLUSION: Post-PLR PVPI effectively predicts fluid-induced early-VC in fluid-tolerant preload-responders, identifying those with poor RVDR. Its use can guide fluid management in cardiac surgery patients, helping to prevent unnecessary fluid administration and associated complications.
TRIAL REGISTRATION: NCT06440772. Registered 30 May 2024. Retrospectively registered.
参考来源
- Morosanu B, Balan C, Boros C, et al. Incidence, predictability, and outcomes of systemic venous congestion following a fluid challenge in initially fluid-tolerant preload-responders after cardiac surgery: a pilot trial. Crit Care. 2024. PMID: 39439007. doi:10.1186/s13054-024-05124-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。